Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Stock buy back///less shares-ronan

RE: Stock buy back///less shares-ronan

posted on Apr 24, 2006 11:13AM
I think a new investor looking at ptsc for the first time and seeing 60 million shares outstanding vs 300+ million and an additional $20-30+ million in the bank makes ptsc a much more attractive stock...not to mention what a nasdaq listing brings to the table.

If market perception is your concern, the otcbb status yields a much weaker perception than does a reverse split done from a position of strength, imo. The exposure to new investment dollars also grows.

I think it would be wise to ask management about this tactic vs dwindling cash reserves in a stock buy-back program at the upcoming shareholders meeting, not in a effort to attack, for they have done a stellar job in bringing this company along in a short period of time, but to rather help shareholders get a sense of where they go from here.

Best regards,

DB

Share
New Message
Please login to post a reply